Home,
Search,
Index,
Links,
Pathology,
Molecules,
Syndromes,
Muscle,
NMJ,
Nerve,
Spinal,
Ataxia,
Antibody & Biopsy,
Patient Info
|
DYSTROPHINOPATHIES: Duchenne
DMD Muscle pathology: General features
- Myopathy: Ongoing & Chronic
- Fiber sizes: Varied
- Small fibers: Round
- Hypercontracted (opaque) muscle fbers
- Necrosis & Regeneration of muscle fibers
- More early in disease course
- Patterns
- Muscle fiber pathology
- "Delta lesions"
- Internal architecture
- Immaturity (2C fiber type): Many fibers
- Hypercontracted fibers
- Chronic changes: Other tissues
- Endomysial connective tissue: Increased
- Fat accumulation
- Locations: Endomysial & Perimysial
- Molecular
- Dystrophin staining
- Screening Antibodies: Target Epitopes
- N-terminus
- Rod domain
- 7G1: vs Exon 46 (Within deletion hotspot)
- 6A9: vs Exon 50 (Within deletion hotspot)
- Dys-1: vs Exons 26 to 30
- C-terminus
- Dys-2: vs Exon 79
- Less useful
- Few deletions in this region
- May be reduced in other myopathies
- Duchenne MD clinical phenotype: Staining patterns
- DMD Muscle
- Dystrophin: Absent staining for all epitopes
- Utrophin: Normal (Absent on muscle fibers) or Increased staining
- nNOS: Often absent with Exon 45-51 hotspot deletions
- Sarcoglycans: Often reduced in Duchenne MD
- Schwann cells: May stain for dystrophin with mutations proximal to Intron 55
- Becker MD clinical phenotype: Staining patterns
- Overall reduced staining for all antibodies
- Relative reduction in intensity of staining for some dystrophin epitopes
- Complete loss of some dystrophin epitopes
- Dystrophin female carriers
- Non-necrotic, dystrophin-negative muscle fibers
- Other sarcolemma-related proteins
- Sarcoglycans: Reduced
- Aquaporin 4: Reduced
- Laminin-α2: Normal or Increased
- Utrophin: Increased
- β-Spectrin: Normal
- Calcium
1
- Increased in myoplasm
- Pathomechanisms of Ca++ increase in DMD muscle fibers
- Enhanced Ca++ leak from sarcoplasmic reticulum (SR)
- Through oxidized Ryanodine receptor type 1 (RyR1) Ca++ release channels
- Hypernitrosylation of cysteine residues in RyR1
- FKBP1A
dissociation from RyR1
- Destabilization of RyR1 channel closed state
- Increased RyR1-dependent SR Ca++ leak
- Uncontrolled production of reactive species
- Oxygen (ROS)
- Nitrogen (RNS)
- Reduced activity of SR/ER Ca++ ATPase(SERCA) (Ca++pump)
- Excessive extracellular Ca++ trans-sarcolemmal influx
- Micro-tears: Delta lesions
- Abnormal Ca++-permeable ion channels
- Enhanced store-operated Ca2+ entry (SOCE)
- Related molecules
- SOCE trigger: Depletion of intracellular Ca++ stores
|
|
From: AG Engel
Delta Lesions (Arrow)
Description: Focal wedge-shaped lesions
Locations: Subsarcolemmal regions of muscle fibers
|
|
DMD
Muscle fibers
Size: Varied
Shape: Small fibers round or polygonal
Internal nuclei
Hypercontracted
Necrosis
Endomysial connective tissue: Increased between muscle fibers
Fat: Increased in endomysium & preimysium
H&E stain
|
DMD Endomysial connective tissue: Increased between muscle fibers
VvG stain
|
NADH stain
|
DMD: Immature muscle fibers
Coarse internal architecture on NADH (Above)
2C fibers: Intermediate staining on ATPase pH 4.3 (Below)
ATPase pH 4.3 stain
|
Duchenne Muscular Dystrophy: Early Pathology
H & E stain
|
|
Muscle fibers
Sizes: Varied; Small fibers are rounded or polygonal; Occasional hypertrophic fiber
Necrosis (Left): Fibers scattered & in small groups
Myopathic groups (Below): Clusters of small necrotic (Black arrow) & regenerating (White arrow) muscle fibers
Internal nuclei: Occasional
Endomysial connective tissue: Normal to mildly increased
Perimysium: Early replacement by fat
|
Acid phosphatase stain
Acid phosphatase + cells
Endomysium: Small Scattered cells
Necrotic muscle fibers: Clusters of phagocytic cells
Ring fibers (Arrow)
|
Acid phosphatase stain
Acid phosphatase + cells
Necrotic muscle fibers: Clusters of phagocytic cells
|
DMD: Muscle Fiber Necrosis
Necrotic Fibers: Scattered; Varied stages
H&E stain
|
Gomori trichrome stain
|
Necrotic Fibers: Scattered; Replaced by cells
VvG stain
|
Myopathic Grouping
Myopathic grouping: Necrotic muscle fibers, clustered
H&E stain
|
Necrosis, Early stage
Necrotic muscle fibers: Pale stained
Macrophages: Early invasion of muscle fibers
NADH stain
Necrotic muscle fibers are pale on NADH stain
|
Myopathic grouping: Clusters of very small regenerating muscle fibers & histiocytic cells
VvG stain
|
Myopathic groups: Clusters of small muscle fibers in similar, early, stage of regeneration or immaturity
VvG stain
|
Myopathic groups: Clusters of small muscle fibers in similar, early, stage of regeneration or immaturity
H & E stain
|
ATPase, pH 4.3
|
NADH
|
Clusters of small cells
Many stain for Acid phosphatase
Acid phosphatase
|
Acid phosphatase
|
H & E stain
|
Myopathic Grouping: Late
H & E stain
|
Myopathic grouping: Intermediate-sized, Immature muscle fibers in clusters
H & E stain
Immature fibers are small & basophilic
|
ATPase, pH 4.3
Immature fibers are: Small & 2C (Intermediate staining)
|
Alkaline phosphatase
Immature small fibers have: Cytoplasmic staining
|
NADH
Immature fibers have coarse cytoplasmic staining
|
NADH
|
VvG
Immature small fibers have coarse cytoplasmic staining
|
Immature muscle fibers: Many
|
|
Staining properties of immature muscle fibers includes:
1. H & E (left): Basophilic fibers
2. Alkaline phosphatase positive (center)
3. 2C fibers: Intermediate staining on ATPase pH 4.3 (right)
|
Duchenne Muscular Dystrophy: Severe at age 2 years
H&E stain
|
DMD
Endomysial connective tissue: Increased
Muscle fibers
Necrosis & Regeneration
Size: Varied
DMD
Endomysial connective tissue: Increased
Muscle fibers
Necrosis & Regeneration
Size: Varied
Gomori trichrome stain
|
Gomori trichrome stain
|
VvG stain
|
DMD
Many intermediate-stained muscle fibers
ATPase pH 4.3 stain
|
Duchenne Muscular Dystrophy: Later Pathology (10 years)
H&E stain
|
DMD: Later pathology
Fiber size: Varied
Endomysial connective tissue: Increased
Fat replacement of muscle: Prominent
H&E stain
|
VvG stain
|
Sudan stain
|
Replacement of Muscle fibers & Perimysial connective tissue by Fat (Dark black)
Sudan stain
|
H&E stain
Endomysial connective tissue: Increased
Fiber size: Variable
Small fibers: Rounded
Large or hypercontracted muscle fibers: Scattered
Necrotic fibers (Arrow): Scattered
|
|
|
H&E stain
Endomysial connective tissue Increased between fibers
|
|
Muscle fiber size: Varied
Small & Large fibers: May be are either type (I = Dark; II = Light)
Many type IIC fibers: Smaller size; Intermediate stain
ATPase pH 4.3 stain
|
DMD late: Few necrotic muscle fibers
Acid phosphatase stain
|
Muscle fiber internal architecture: Coarse
NADH stain
|
DMD: Ring Fibers
H&E stain
|
Gomori trichrome stain
|
NADH stain
|
DMD: Ring fibers
NADH stain
|
Dystrophin staining
Normal
|
Duchenne Muscular Dystrophy:
|
Normal dystrophin staining
around the rim of muscle fibers.
|
Absent dystrophin: Duchenne muscular dystrophy
Left: No staining around the rim of any muscle fibers
Right: No staining of most muscle fibers
One "revertant" fiber with dystrophin staining.
Revertant fibers reflect a somatic mutation allowing dystrophin expression
|
Normal: Dystrophin present near surface of muscle fibers
Dys1 stain
Duchenne MD: Dystrophin absent from surface of muscle fibers
Dys1 stain
|
Muscle from Duchenne MD male with large area of revertant muscle fibers
Muscle histology (Above): One fascicle (Arrow) has more normal muscle fibers & connective tissue amid otherwise myopathic muscle
Dystrophin staining (Below): Muscle fibers in preserved fascicle are revertants with dystrophin present around their rim
Some revertant muscle fibers are present in myopathic regions as well.
Western blot: Dystrophin from dystrophinopathies
from Novocastra
Lane 1: Becker dystrophy;
Dystrophin has reduced abundance but normal size.
Lane 2: Becker dystrophy; Dystrophin has reduced size and abundance.
Lane 3: Normal; Dystrophin has normal size and amount.
Lane 4: Duchenne dystrophy; Almost no protein is present.
Lane 5: Duchenne outlier; Dystrophin has severely reduced abundance.
|
Go to
Becker muscular dystrophy pathology
Return to
Dystrophinopathies.
Return to
Neuromuscular syndromes
Return to
Neuromuscular home page
References
1.
J Gen Physiol 2022;15:e202213081
8/2/2023